Nikko Asset Management Americas, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Nikko Asset Management Americas, Inc.
- $8.95 Billion
- Q4 2024
A detailed history of Nikko Asset Management Americas, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 26,154 shares of REGN stock, worth $17.6 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
26,154
Previous 28,884
9.45%
Holding current value
$17.6 Million
Previous $30.4 Million
38.64%
% of portfolio
0.21%
Previous 0.35%
Shares
24 transactions
Others Institutions Holding REGN
# of Institutions
1,489Shares Held
85.6MCall Options Held
1.54MPut Options Held
1.46M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.26 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.69 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.76 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.25 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.19 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $72.2B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...